“Effectiveness and Safety After a Switch to Tildrakizumab: A Real World Multicenter Italian Study in Psoriasis”. 2023. Dermatology Practical & Conceptual 13 (4): e2023215. https://doi.org/10.5826/dpc.1304a215.